**Core Concept**
The combination of sulfamethoxazole and trimethoprim is a classic example of bacteriostatic synergy in the treatment of bacterial infections. Sulfamethoxazole is a sulfonamide antibiotic that inhibits dihydropteroate synthase, an enzyme essential for the synthesis of tetrahydrofolate (THF). Trimethoprim, on the other hand, inhibits dihydrofolate reductase (DHFR), another enzyme required for THF synthesis.

**Why the Correct Answer is Right**
The synergy between sulfamethoxazole and trimethoprim arises from their sequential inhibition of the folate synthesis pathway. Sulfamethoxazole blocks the entry of para-aminobenzoic acid (PABA) into the synthesis of THF, while trimethoprim inhibits the reduction of dihydrofolate to THF. By targeting two consecutive steps in the same pathway, the combination of sulfamethoxazole and trimethoprim effectively prevents bacterial growth and replication. This synergistic effect is particularly useful in treating infections caused by susceptible bacteria, such as Escherichia coli and Staphylococcus aureus.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the underlying mechanism of synergy between sulfamethoxazole and trimethoprim.

**Option B:** This option is incorrect because it does not accurately describe the sequential inhibition of the folate synthesis pathway by sulfamethoxazole and trimethoprim.

**Option C:** This option is incorrect because it does not provide a clear explanation of the synergy between sulfamethoxazole and trimethoprim.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that the combination of sulfamethoxazole and trimethoprim is often used to treat urinary tract infections, respiratory tract infections, and skin infections, particularly in patients with compromised immune systems. The synergistic effect of this combination makes it an effective treatment option for a wide range of bacterial infections.

**Correct Answer:** C.